QL
IOVA icon

Quarry LP’s Iovance Biotherapeutics IOVA Stock Holding History

Quarry LP’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68K Buy
+645
New +$2.45K ﹤0.01% 1440
2025
Q2 		– Sell
-23,000
Closed -$76.6K – 1878
2025
Q1 		$76.6K Buy
23,000
+13,000
+130% +$67K 0.02% 622
2024
Q4 		$74K Buy
+10,000
New +$92.7K 0.01% 558

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Quarry LP's IOVA Position: Q2 2026 in Review

Quarry LP opened a new position in Iovance Biotherapeutics (IOVA) in Q2 2026: 645 shares worth $2.68K. The stake represents ﹤0.01% of the portfolio and ranks #1440 among its holdings. This is a return to the name: Quarry LP previously reported a position in IOVA as recently as Q1 2025.

Quarry LP first reported a position in IOVA in Q4 2024 and has held it in 3 quarters since. The position peaked at $76.6K in Q1 2025. 293 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Quarry LP held 645 shares of Iovance Biotherapeutics worth $2.68K as of Q2 2026.
  • Iovance Biotherapeutics was a new Quarry LP position in Q2 2026.
  • Iovance Biotherapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1440 holding.
  • Quarry LP first reported a position in Iovance Biotherapeutics in Q4 2024 and has held it in 3 quarters since.
  • Quarry LP's Iovance Biotherapeutics position peaked at $76.6K in Q1 2025.
  • 293 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.